Zdrowie i gospodarka · 19/03/2003
FDA Issues Revised Guidance on Bioavailability and Bioequivalence Studies for Orally Administered Drug Products
The Food and Drug Administration (FDA) has released a revised guidance document, updating its 2000 guidance on bioavailability and bioequivalence studies for orally administered drug products, providing general considerations for industry.
Source: Federal Register — Food and Drug AdministrationOpen original release →